|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis显示文摘AIM To assess the performance of proposed scores specific for acute-on-chronic liver failure in predicting shortterm mortality among patients with alcoholic hepatitis.METHODS We retrospectively collected data from 264 patients with clinically diagnosed alcoholic hepatitis from January to December 2013 at 21 academic hospitals in Korea. The performance for predicting short-term mortality was calculated for Chronic Liver FailureSequential Organ Failure Assessment(CLIF-SOFA), CLIF Consortium Organ Failure score(CLIF-C OFs), Maddrey'sdiscriminant function(DF), age, bilirubin, international normalized ratio and creatinine score(ABIC), Glasgow Alcoholic Hepatitis Score(GAHS), model for end-stage liver disease(MELD), and MELD-Na.RESULTS Of 264 patients, 32(12%) patients died within 28 d. The area under receiver operating characteristic curve of CLIF-SOFA, CLIF-C OFs, DF, ABIC, GAHS, MELD, and MELD-Na was 0.86(0.81-0.90), 0.89(0.84-0.92), 0.79(0.74-0.84), 0.78(0.72-0.83), 0.81(0.76-0.86), 0.83(0.78-0.88), and 0.83(0.78-0.88), respectively, for 28-d mortality. The performance of CLIF-SOFA had no statistically significant differences for 28-d mortality. The performance of CLIF-C OFs was superior to that of DF, ABIC, and GAHS, while comparable to that of MELD and MELD-Na in predicting 28-d mortality. A CLIF-SOFA score of 8 had 78.1% sensitivity and 79.7% specificity, and CLIF-C OFs of 10 had 68.8% sensitivity and 91.4% specificity for predicting 28-d mortality.CONCLUSION CLIF-SOFA and CLIF-C OF scores performed well, with comparable predictive ability for short-term mortality compared to the commonly used scoring systems in patients with alcoholic hepatitis. | Hee Yeon Kim Chang Wook Kim Tae Yeob Kim Do Seon Song Dong Hyun Sinn Eileen L Yoon Young Kul Jung Ki Tae Suk Sang Soo Lee Chang Hyeong Lee Tae Hun Kim Jeong Han Kim Hyung Joon Yim Sung Eun Kim Soon Koo Baik Byung Seok Lee Jae Young Jang Young Seok Kim Sang Gyune Kim Jin Mo Yang Joo Hyun Sohn Heon Ju Lee Seung Ha Park Eun Hee Choi Dong Joon Kim Korean Acute-on-Chronic Liver Failure Study Group | 2016 | World Journal of Gastroenterology2016，22，41： | 5 |
| 2 | Interstitial tissue-specific gene expression in mouse testis by intra-tunica albuguineal injection of recombinant baculovirus显示文摘这研究的目的是用修改 recombinant baculovirus 在鼠标睾丸为空隙的织物特定的蛋白质表示建立一个基因交货系统。格林荧光灯表示 recombinant baculovirus (GFP-baculovirus ) 的蛋白质(GFP ) ,在哪个昆虫房间特定的多面体倡导者被 cytomegalovirus (CMV ) 代替 IE 倡导者,习惯于 transfect 在 vitro 的阴囊的房间,并且为睾丸的空隙的织物的 intra-tunica albuguineal 注射。GFP 表示被荧光显微镜学在冻结的睾丸节监视。在阴囊的纸巾的 GFP 的表示被反向的抄写聚合酶链反应(RT-PCR ) 也估计,并且蛋白质表示被西方的污点估计。在 vitro 的阴囊的房间被修改 recombinant GFP-baculovirus 高效地感染。进老鼠睾丸的 GFP-baculovirus 的 Intra-tunica albuguineal 注射在空隙的纸巾导致了 GFP 表示的高水平。RT-PCR 分析清楚地在睾丸显示出 GFP 基因表示,特别地空隙的纸巾。编码了 recombinant 老鼠的修改 baculovirus 的 Intra-tunica albuguineal 注射像胰岛素的生长因素绑定蛋白质(IGFBP )-5 导致了睾丸和精液的 IGFBP-5 的增加。在结论,我们在阴囊的房间在 vivo 为基因表示开发了一个有效交货系统,特别地用修改 recombinant baculovirus 的 intra-tunica albuguineal 注射的空隙的织物的房间。这个方法将为在睾丸的外部生精的小管的阴囊的房间要求基因交货和蛋白质表示的申请是特别地相关的。 | Hyun Jung Park Won Young Lee Jin Hoi Kim Jae Hwan Kim Hun Jong Jung Nam Hyung Kim Bo Kyung Kim Hyuk Song | 2009 | Asian Journal of Andrology2009，11，3： | 3 |
| 3 | Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study显示文摘Background:Combination therapy with oxaliplatin,irinotecan,fluorouracil,and leucovorin(FOLFIRINOX)chemotherapy drastically improves survival of advanced pancreatic cancer patients.However,the efficacy of FOLFIRINOX as a second-line treatment after gemcitabine failure has not been tested prospectively.We investigated the feasibility and safety of attenuated FOLFIRINOX in patients with gemcitabine-refractory advanced pancreatic cancer.Methods:A multicenter phase II prospective open-label,single-arm study was conducted at 14 hospitals.Patients with histologically proven invasive ductal pancreatic adenocarcinoma,a measurable or evaluable lesion,Eastern Cooperative Oncology Group performance status 0 or 1,adequate organ function,and aged 19 years or older were eligible.Attenuated FOLFIRINOX consisted of oxaliplatin 65 mg/m2,irinotecan 135 mg/m2,and leucovorin 400 mg/m2 injected intravenously on day 1 and 5-fluorouracil 2000 mg/m2 continuously infused intravenously over 46 h on days 1-2,repeated every 2 weeks.The primary endpoint was progression-free survival from the initiation of FOLFIRINOX.Secondary endpoints were the objective response rate,disease control rate,overall survival,safety,and tolerability.We estimated overall survival and progression-free survival using the Kaplan-Meier methods.Results:We enrolled 39 patients from 14 institutions.The objective response rate was 10.3%,while the disease control rate was 64.1%.The 6-month and 1-year overall survival rates were 59.0%and 15.4%,respectively.Median progression-free survival and overall survival were 3.8 months(95%confidence interval[CI]1.5-6.0 months)and 8.5 months(95%CI 5.6-11.4 months),respectively.Grade 3 or 4 adverse events were neutropenia(41.0%),nausea(10.3%),anorexia(10.3%),anemia(7.7%),mucositis(7.7%),pneumonia/pleural effusion(5.1%),and fatigue(5.1%).One treatment-related death attributable to septic shock occurred.Conclusion:Attenuated FOLFIRINOX may be promising as a second-line therapy for gemcitabine-refractory pancre-atic cancer. | Jung Hoon Kim Sang-Cheol Lee Sung Yong Oh Seo-Young Song Namsu Lee Eun Mi Nam Soonil Lee In Gyu Hwang Hyo Rak Lee Kyu Taek Lee Sang-Byung Bae Han Jo Kim Joung Soon Jang Do Hyoung Lim Hyun Woo Lee Seok Yun Kang Jung Hun Kang | 2018 | Cancer Communications2018，38，1： | 2 |
| 4 | Autologous Adipose Tissue‐Derived Stem Cells Treatment Demonstrated Favorable and Sustainable Therapeutic Effect for Crohn’s Fistula显示文摘 | Woo Yong Lee Kyu Joo Park Yong Beom Cho Sang Nam Yoon Kee Ho Song Do Sun Kim Sang Hun Jung Mihyung Kim Hee‐Won Yoo Inok Kim Hunjoo Ha Chang Sik Yu | 2013 | Stem Cells2013，，11： | 2 |
| 5 | Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study显示文摘 | Hyun Joo Jang Jung Han Kim Hun Ho Song Kyung Hee Woo Mi Kim Sea Hyub Kae Jin Lee Ji Wong Cho Jung Hun Kang Soon Il Lee Soo Jung Gong Jung Ae Lee Dae Young Zang | 2008 | Digestive Diseases and Sciences2008，，2： | 1 |
| 6 | Long‐term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation显示文摘 | Shin Hwang Sung‐Gyu Lee Kyu‐Bo Sung Kwang‐Min Park Ki‐Hun Kim Chul‐Soo Ahn Young‐Joo Lee Sung‐Koo Lee Gyu‐Sam Hwang Deok‐Bog Moon Tae‐Yong Ha Dong‐Sik Kim Jae‐Pil Jung Gi‐Won Song | 2006 | Liver Transpl2006，，5： | 1 |
| 7 | Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions显示文摘 | Jung Ok Park Do‐Young Choi Dong‐Sic Choi Hee Joung Kim Jeong Won Kang Jae Hun Jung Jeong Hwa Lee Jayoung Kim Michael R. Freeman Kye Young Lee Yong Song Gho Kwang Pyo Kim | 2013 | Proteomics2013，，14： | 1 |
| 8 | Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience显示文摘 | Sung Gyu Lee Gi Won Song Shin Hwang Tae Yong Ha Deok Bog Moon Dong Hwan Jung Ki Hun Kim Chul Soo Ahn Myung Hwan Kim Sung Koo Lee Kyu Bo Sung Gi Young Ko | 2010 | Journal of Hepato-Biliary-Pancreatic Sciences2010，，： | 1 |
| 9 | Reconstruction of inferior right hepatic veins in living donor liver transplantation using right liver grafts显示文摘 | Shin Hwang Tae‐Yong Ha Chul‐Soo Ahn Deok‐Bog Moon Ki‐Hun Kim Gi‐Won Song Dong‐Hwan Jung Gil‐Chun Park Jung‐Man Namgoong Sung‐Won Jung Sam‐Youl Yoon Kyu‐Bo Sung Gi‐Young Ko Byungchul Cho Kyoung Won Kim Sung‐Gyu Lee | 2012 | Liver Transpl2012，，2： | 1 |
| 10 | Hemodynamics‐compliant reconstruction of the right hepatic vein for adult living donor liver transplantation with a right liver graft显示文摘 | Shin Hwang Tae‐Yong Ha Chul‐Soo Ahn Deok‐Bog Moon Gi‐Won Song Ki‐Hun Kim Dong‐Hwan Jung Gil‐Chun Park Kyu‐Bo Sung Gi‐Young Ko Kyoung Won Kim Byungchul Cho Jung‐Man Namgoong Sung‐Won Jung Sam‐Youl Yoon Chun‐Soo Park Yo‐Han Park Hyeong‐Woo Park Hyo‐Jun Lee | 2012 | Liver Transpl2012，，7： | 1 |
| 11 | Interaction of tetraspan(in) TM4SF5 with CD44 promotes self‐renewal and circulating capacities of hepatocarcinoma cells显示文摘 | Doohyung Lee Juri Na Jihye Ryu Hye‐Jin Kim Seo Hee Nam Minkyung Kang Jae Woo Jung Mi‐Sook Lee Haeng Eun Song Jungeun Choi Gyu‐Ho Lee Tai Young Kim June‐Key Chung Ki Hun Park Sung‐Hak Kim Hyunggee Kim Howon Seo Pilhan Kim Hyewon Youn Jung Weon Lee | 2015 | Hepatology2015，，6： | 1 |
| 12 | Usability of ringed polytetrafluoroethylene grafts for middle hepatic vein reconstruction during living donor liver transplantation显示文摘 | Shin Hwang Dong‐Hwan Jung Tae‐Yong Ha Chul‐Soo Ahn Deok‐Bog Moon Ki‐Hun Kim Gi‐Won Song Gil‐Chun Park Sung‐Won Jung Sam‐Youl Yoon Jung‐Man Namgoong Chun‐Soo Park Yo‐Han Park Hyeong‐Woo Park Hyo‐Jun Lee Sung‐Gyu Lee | 2012 | Liver Transpl2012，，8： | 1 |
| 13 | Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis显示文摘 | Jwa-Kyung Kim Sungha Park Mi Jung Lee Young Rim Song Seung Hyeok Han Sung Gyun Kim Shin-Wook Kang Kyu Hun Choi Hyung Jik Kim Tae-Hyun Yoo | 2011 | Atherosclerosis2011，，1： | 1 |
| 14 | Robot-assisted distal gastrectomy for gastric cancer: initial experience显示文摘 | Han Hong Lee Hoon Hur Hun Jung Hae Myung Jeon Cho Hyun Park Kyo Young Song | 2011 | The American Journal of Surgery2011，，6： | 1 |
| 15 | Influence of the BRAF V600E mutation on expression of VEGF in papillary thyroid cancer显示文摘 | Young Suk Jo Shengjin Li Jung Hun Song | 2006 | J Clin Endocrin Metab2006，10，1210： | 1 |
| 16 | Development of controlled release bi-layered tablets containing oxycodone hydrochloride显示文摘Oxycodone hydrochloride is a semi-synthetic opioid agonist that provides very effective relief for moderate to severe pain in cancer and post-operative patients. Controlled release oxycodone formulations have been studied to enhance the therapeutic effect by providing constant release over the whole dosing interval and improve patient’s convenience by reducing the frequency of administration as well. | Kyung Hun Kim Kyung Soo Lee Il Woo Jung Jin Seob Oh Seo Hyun Lim Sung Hoon Lee Woo Heon Song Jun Sang Park | 2016 | Asian Journal of Pharmaceutical Sciences2016，11，1： | 0 |
| 17 | 减量FOLFIRINOX方案挽救性治疗吉西他滨抵抗的晚期胰腺癌:一项Ⅱ期研究显示文摘背景与目的奥沙利铂、伊立替康、氟尿嘧啶和亚叶酸的联合化疗方案(FOLFIRINOX)极大提高了晚期胰腺癌患者的生存期。然而,FOLFIRINOX方案作为吉西他滨失败后二线治疗的疗效尚未进行前瞻性的检测。我们研究了减量FOLFIRINOX方案治疗吉西他滨抵抗的晚期胰腺癌患者的可行性和安全性。方法在14家医院进行了这一多中心II期前瞻、开放标签的单臂研究。经组织学确诊为胰腺浸润性导管腺癌、有可测量或可评价的病灶、东部肿瘤协作组体能状况评分0或1分、器官功能良好、年龄19岁或以上的患者符合入组条件。减量FOLFIRINOX方案的组成:奥沙利铂65 mg/m2、伊立替康135 mg/m2和亚叶酸400 mg/m2,第1天静脉注射;5?氟尿嘧啶2000 mg/m2,第1–2天持续静脉输注46 h;每2周重复。主要终点为FOLIFLIOX治疗起始后的无进展生存期。次要终点为客观缓解率、疾病控制率、总生存期、安全性和耐受性。采用Kaplan?Meier法评估了总生存期和无进展生存期。结果我们招募了来自14个中心的39例患者。客观缓解率为10.3%,疾病控制率为64.1%。6个月和1年总生存率分别为59.0%和15.4%。中位无进展生存期和总生存期分别为3.8个月[95%置信区间(confidence interval,CI)=1.5–6.0个月]和8.5个月(95%CI=5.6–11.4个月)。3或4级不良事件为中性粒细胞减少(41%)、恶心(10.3%)、食欲减退(10.3%)、贫血(7.7%)、黏膜炎(7.7%)、肺炎/胸膜融合(5.1%)和乏力(5.1%)。发生1例由感染性休克引起的治疗相关死亡。结论减量FOLFIRINOX方案有望作为二线方案治疗吉西他滨抵抗的胰腺癌。 | Jung Hoon Kim Sang-Cheol Lee Sung Yong Oh Seo-Young Song Namsu Lee Eun Mi Nam Soonil Lee In Gyu Hwang Hyo Rak Lee Kyu Taek Lee Sang-Byung Bae Han Jo Kim Joung Soon Jang Do Hyoung Lim Hyun Woo Lee Seok Yun Kang Jung Hun Kang | 2018 | 癌症2018，37，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员